Literature DB >> 19821642

Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility.

Eveline C van Asbeck1, Karl V Clemons, David A Stevens.   

Abstract

The Candida parapsilosis family has emerged as a major opportunistic and nosocomial pathogen. It causes multifaceted pathology in immuno-compromised and normal hosts, notably low birth weight neonates. Its emergence may relate to an ability to colonize the skin, proliferate in glucose-containing solutions, and adhere to plastic. When clusters appear, determination of genetic relatedness among strains and identification of a common source are important. Its virulence appears associated with a capacity to produce biofilm and production of phospholipase and aspartyl protease. Further investigations of the host-pathogen interactions are needed. This review summarizes basic science, clinical and experimental information about C. parapsilosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19821642     DOI: 10.3109/10408410903213393

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  64 in total

1.  Adhesins in Candida parapsilosis: Understudied players in virulence.

Authors:  Attila Gacser
Journal:  Virulence       Date:  2015-12-29       Impact factor: 5.882

2.  The stearoyl-coenzyme A desaturase 1 is essential for virulence and membrane stress in Candida parapsilosis through unsaturated fatty acid production.

Authors:  Long Nam Nguyen; Attila Gacser; Joshua D Nosanchuk
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

3.  Microsatellite genotyping clarified conspicuous accumulation of Candida parapsilosis at a cardiothoracic surgery intensive care unit.

Authors:  Magda Diab-Elschahawi; Christina Forstner; Ferry Hagen; Jacques F Meis; Andrea M Lassnig; Elisabeth Presterl; Corné H W Klaassen
Journal:  J Clin Microbiol       Date:  2012-08-08       Impact factor: 5.948

4.  Candida parapsilosis: an emerging pathogen developing its own identity.

Authors:  Joseph M Bliss
Journal:  Virulence       Date:  2015       Impact factor: 5.882

Review 5.  Investigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How?

Authors:  Alexandre Alanio; Marie Desnos-Ollivier; Dea Garcia-Hermoso; Stéphane Bretagne
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

Review 6.  Thriving within the host: Candida spp. interactions with phagocytic cells.

Authors:  Pedro Miramón; Lydia Kasper; Bernhard Hube
Journal:  Med Microbiol Immunol       Date:  2013-01-25       Impact factor: 3.402

7.  Increase in Candida parapsilosis fungemia in critical care units: a 6-years study.

Authors:  Elif Sahin Horasan; Gülden Ersöz; Musa Göksu; Feza Otag; Ahmet Oner Kurt; Sevim Karaçorlu; Ali Kaya
Journal:  Mycopathologia       Date:  2010-06-04       Impact factor: 2.574

Review 8.  Candida parapsilosis and the neonate: epidemiology, virulence and host defense in a unique patient setting.

Authors:  Brian D W Chow; Jennifer R Linden; Joseph M Bliss
Journal:  Expert Rev Anti Infect Ther       Date:  2012-08       Impact factor: 5.091

9.  Genetic Diversity and Antifungal Susceptibility of Candida parapsilosis Sensu Stricto Isolated from Bloodstream Infections in Turkish Patients.

Authors:  Süleyha Hilmioğlu-Polat; Somayeh Sharifynia; Yasemin Öz; Müge Aslan; Nuray Gündoğdu; Ayşe Serin; Haleh Rafati; Faezeh Mohammadi; Dilek Yeşim-Metin; Aylin Döğen; Macit Ilkit; Seyedmojtaba Seyedmousavi
Journal:  Mycopathologia       Date:  2018-05-03       Impact factor: 2.574

10.  Characterization of Virulence-Related Phenotypes in Candida Species of the CUG Clade.

Authors:  Shelby J Priest; Michael C Lorenz
Journal:  Eukaryot Cell       Date:  2015-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.